GoodRx Holdings (GDRX) EBT (2019 - 2026)

GoodRx Holdings has disclosed EBT across 8 years of filings, most recently posting $5.6 million for Q1 2026.

• EBT for Q1 2026 came in at $5.6 million, down 66.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.5 million (down 4.86% YoY), and the FY2025 annual result was $56.5 million, up 79.71% from the prior year.
• EBT came in at $5.6 million for Q1 2026 at GoodRx Holdings, down from $14.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $19.6 million in Q2 2025 to a low of -$46.6 million in Q3 2023.
• The 5-year median for EBT is $6.1 million (2025), against an average of $872588.2.
• Across the five-year window, EBT tumbled 2154.52% in 2022 and soared 5588.74% in 2025, its largest moves.
• GoodRx Holdings' EBT stood at -$4.7 million in 2022, then tumbled by 419.18% to -$24.6 million in 2023, then jumped by 146.31% to $11.4 million in 2024, then rose by 24.4% to $14.2 million in 2025, then tumbled by 60.27% to $5.6 million in 2026.
• The last three EBT figures came in at $5.6 million (Q1 2026), $14.2 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.